MGKAX
Price
$14.19
Change
+$0.10 (+0.71%)
Updated
Jul 2 closing price
Net Assets
4.22M
NPFCX
Price
$65.16
Change
+$0.36 (+0.56%)
Updated
Jul 3 closing price
Net Assets
155.36B
Interact to see
Advertisement

MGKAX vs NPFCX

Header iconMGKAX vs NPFCX Comparison
Open Charts MGKAX vs NPFCXBanner chart's image
Morgan Stanley Global Permanence A
Price$14.19
Change+$0.10 (+0.71%)
VolumeN/A
Net Assets4.22M
American Funds New Perspective C
Price$65.16
Change+$0.36 (+0.56%)
VolumeN/A
Net Assets155.36B
MGKAX vs NPFCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MGKAX vs. NPFCX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGKAX is a Buy and NPFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 155B vs. MGKAX (4.22M). MGKAX pays higher dividends than NPFCX: MGKAX (2.30) vs NPFCX (0.00). MGKAX was incepted earlier than NPFCX: MGKAX (6 years) vs NPFCX (24 years). MGKAX (8.22) is less costly to investors than NPFCX (1.48). MGKAX is a more actively managed with annual turnover of: 62.00 vs. NPFCX (24.00). NPFCX has a lower initial minimum investment than MGKAX: NPFCX (250) vs MGKAX (1000). MGKAX annual gain was more profitable for investors over the last year : 13.45 vs. NPFCX (10.10). NPFCX return over 5 years is better than : 40.07 vs. MGKAX (31.20).
MGKAXNPFCXMGKAX / NPFCX
Total Expense Ratio1.351.4891%
Annual Report Gross Expense Ratio8.221.48555%
Fund Existence6 years24 years-
Gain YTD26.47112.539211%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets4.22M155B0%
Annual Yield % from dividends2.300.00-
Returns for 1 year13.4510.10133%
Returns for 3 years41.1243.1495%
Returns for 5 years31.2040.0778%
Returns for 10 yearsN/A77.31-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDTC2.200.08
+3.61%
CytoMed Therapeutics Limited
BLDE4.180.05
+1.21%
Blade Air Mobility
LULU247.681.38
+0.56%
lululemon athletica
ACA90.020.35
+0.39%
Arcosa
DYN8.76-0.18
-2.01%
Dyne Therapeutics